High Flow Humidified Nasal Cannula versus Standardised Oxygen Therapy

Not Applicable

Completed

• Conditions: Respiratory - Other respiratory disorders / diseases; Respiratory; Dyspnoea

• Registration Number: ACTRN12613001264774
• Lead Sponsor: erida Bell

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2013-11-18
• Last Update Posted: 13 January 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Patients who are 16years and over who present with dyspnoea and a respiratory rate great or equal to 25 and oxygen saturations of less than or equal to 93% on room air to either Royal Prince Alfred ED or Canterbury Hospital ED

Exclusion Criteria

1. Patients presenting to the ED who require immediate BiPAP or intubation/ventilation
2. Any patient under the age 16
3. Patients who have received a trauma call; including facial trauma, chest trauma
4. Patients with suspected spontaneous pneumothorax
5. Patients who are unable to provide informed consent (cognitive impairment, intoxication from drugs and/or alcohol, intellectual disability, mental illness)

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Success will be determined by a decrease in the patient’s respiratory rate by 20% without requiring escalation to either humidified high flow, non invasive ventilation or invasive ventilation. The need for escalation will be at the discretion of the treating clinician.<br><br>The primary outcome between the two groups will be compared using Chi Square tests.[At the end of the second hour from the time therapy is commenced]